S. Fedevych Danylo Halytsky Lviv National Medical University Introduction. Implementing into medical practice target therapy in cancer patients including the conventional (clear cell) renal cell carcinoma (CCRCC) provides the delivery of anti-angiogenic and conventional cytoreductive agents through “normalized” ways of the vascular network of tumors to cancer cells. We also know that microcirculatory bed and Read More …